Subchapter III: NATIONAL RESEARCH INSTITUTES
Part A: National Institutes of Health
- Section 281: Organization of National Institutes of Health
- Section 282: Director of National Institutes of Health
- Section 282a: Authorization of appropriations
- Section 282b: Electronic coding of grants and activities
- Section 282c: Public access to funded investigators’ final manuscripts
- Section 282d: Transferred
- Section 283: Triennial reports of Director of NIH
- Section 283a: Annual reporting to increase interagency collaboration and coordination
- Section 283a–1: Annual reporting to prevent fraud and abuse
- Section 283a–2: Annual reporting regarding training of graduate students for doctoral degrees
- Section 283a–3: Establishment of program regarding DES
- Section 283b: Repealed. Pub. L. 106–525, title I, § 101(b)(2), Nov. 22, 2000, 114 Stat. 2501
- Section 283c: Office of Behavioral and Social Sciences Research
- Section 283d: Children’s Vaccine Initiative
- Section 283e: Plan for use of animals in research
- Section 283f: Requirements regarding surveys of sexual behavior
- Section 283g: Muscular dystrophy; initiative through Director of National Institutes of Health
- Section 283h, 283i: Transferred
- Section 283j: Repealed. Pub. L. 114–255, div. A, title II, § 2042(f)(1), Dec. 13, 2016, 130 Stat. 1073
- Section 283k: Biomedical and behavioral research facilities
- Section 283l: Construction of regional centers for research on primates
- Section 283m: Sanctuary system for surplus chimpanzees
- Section 283n: Shared Instrumentation Grant Program
- Section 283o: Next generation of researchers
- Section 283p: Population focused research
- Section 283q: Eureka prize competitions
Part B: General Provisions Respecting National Research Institutes
- Section 284: Directors of national research institutes
- Section 284a: Advisory councils
- Section 284b: Repealed. Pub. L. 109–482, title I, § 104(b)(1)(C), Jan. 15, 2007, 120 Stat. 3693
- Section 284c: Certain uses of funds
- Section 284d: Definitions
- Section 284e: Research on osteoporosis, Paget’s disease, and related bone disorders
- Section 284f: Parkinson’s disease
- Section 284g: Expansion, intensification, and coordination of activities of National Institutes of Health with respect to research on autism spectrum disorder
- Section 284h: Pediatric Research Initiative
- Section 284i: Autoimmune diseases
- Section 284j: Muscular dystrophy research
- Section 284k: Clinical research
- Section 284l: Enhancement awards
- Section 284m: Program for pediatric studies of drugs
- Section 284m–1: Pediatric Advisory Committee
- Section 284n: Certain demonstration projects
- Section 284o: Activities of the National Institutes of Health with respect to research on paralysis
- Section 284p: Activities of the National Institutes of Health with respect to research with implications for enhancing daily function for persons with paralysis
- Section 284q: Pain research
- Section 284q–1: NIH opioid research
- Section 284r: Basic research
- Section 284s: Tick-borne diseases
Part C: Specific Provisions Respecting National Research Institutes
- Subpart 1: national cancer institute
- Section 285: Purpose of Institute
- Section 285a: National Cancer Program
- Section 285a–1: Cancer control programs
- Section 285a–2: Special authorities of Director
- Section 285a–3: National cancer research and demonstration centers
- Section 285a–4: President’s Cancer Panel; establishment, membership, etc., functions
- Section 285a–5: Associate Director for Prevention; appointment; function
- Section 285a–6: Breast and gynecological cancers
- Section 285a–7: Prostate cancer
- Section 285a–8: Repealed. Pub. L. 109–482, title I, § 103(b)(15), Jan. 15, 2007, 120 Stat. 3687
- Section 285a–9: Grants for education, prevention, and early detection of radiogenic cancers and diseases
- Section 285a–10: Research, information, and education with respect to blood cancer
- Section 285a–11: Pediatric cancer research, awareness, and survivorship
- Section 285a–11a: Cancer survivorship programs
- Section 285a–11b: Best practices for long-term follow-up services for pediatric cancer survivors
- Section 285a–12: Interagency Breast Cancer and Environmental Research Coordinating Committee
- Section 285a–13: Scientific framework for recalcitrant cancers
- Subpart 2: national heart, lung, and blood institute
- Section 285b: Purpose of Institute
- Section 285b–1: Heart, blood vessel, lung, and blood disease prevention and control programs
- Section 285b–2: Information and education
- Section 285b–3: National Heart, Blood Vessel, Lung, and Blood Diseases and Blood Resources Program; administrative provisions
- Section 285b–4: National research and demonstration centers
- Section 285b–5: Repealed. Pub. L. 100–607, title I, § 129, Nov. 4, 1988, 102 Stat. 3055
- Section 285b–6: Associate Director for Prevention; appointment; function
- Section 285b–7: National Center on Sleep Disorders Research
- Section 285b–7a: Heart attack, stroke, and other cardiovascular diseases in women
- Section 285b–7b: Coordination of Federal asthma activities
- Section 285b–7c: Tuberculosis
- Section 285b–8: Congenital heart disease
- Subpart 3: national institute of diabetes and digestive and kidney diseases
- Section 285c: Purpose of Institute
- Section 285c–1: Data systems and information clearinghouses
- Section 285c–2: Division Directors for Diabetes, Endocrinology, and Metabolic Diseases, Digestive Diseases and Nutrition, and Kidney, Urologic, and Hematologic Diseases; functions
- Section 285c–3: Interagency coordinating committees
- Section 285c–4: Advisory boards
- Section 285c–5: Research and training centers; development or expansion
- Section 285c–6: Advisory council subcommittees
- Section 285c–7: Biennial report
- Section 285c–8: Nutritional disorders program
- Section 285c–9: Juvenile diabetes
- Subpart 4: national institute of arthritis and musculoskeletal and skin diseases
- Section 285d: Purpose of Institute
- Section 285d–1: National arthritis and musculoskeletal and skin diseases program
- Section 285d–2: Research and training
- Section 285d–3: Data system and information clearinghouse
- Section 285d–4: Interagency coordinating committees
- Section 285d–5: Arthritis and musculoskeletal diseases demonstration projects
- Section 285d–6: Multipurpose arthritis and musculoskeletal diseases centers
- Section 285d–6a: Lupus
- Section 285d–7: Advisory Board
- Section 285d–8: Juvenile arthritis and related conditions
- Subpart 5: national institute on aging
- Section 285e: Purpose of Institute
- Section 285e–1: Special functions
- Section 285e–2: Alzheimer’s Disease centers
- Section 285e–3: Claude D. Pepper Older Americans Independence Centers
- Section 285e–4: Awards for leadership and excellence in Alzheimer’s disease and related dementias
- Section 285e–5: Research relevant to appropriate services for individuals with Alzheimer’s disease and related dementias and their families
- Section 285e–6: Dissemination of research results
- Section 285e–7: Clearinghouse on Alzheimer’s Disease
- Section 285e–8: Dissemination project
- Section 285e–9: Alzheimer’s disease registry
- Section 285e–10: Aging processes regarding women
- Section 285e–10a: Alzheimer’s clinical research and training awards
- Section 285e–11: Repealed. Pub. L. 109–482, title I, § 103(b)(26), Jan. 15, 2007, 120 Stat. 3688
- Subpart 6: national institute of allergy and infectious diseases
- Section 285f: Purpose of Institute
- Section 285f–1: Research centers regarding chronic fatigue syndrome
- Section 285f–2: Research and research training regarding tuberculosis
- Section 285f–3: Sexually transmitted disease clinical research and training awards
- Section 285f–4: Microbicide research and development
- Subpart 7: eunice kennedy shriver national institute of child health and human development
- Section 285g: Purpose of Institute
- Section 285g–1: Sudden infant death syndrome research
- Section 285g–2: Research on intellectual disabilities
- Section 285g–3: Associate Director for Prevention; appointment; function
- Section 285g–4: National Center for Medical Rehabilitation Research
- Section 285g–5: Research centers with respect to contraception and infertility
- Section 285g–6: Program regarding obstetrics and gynecology
- Section 285g–7: Child health research centers
- Section 285g–8: Prospective longitudinal study on adolescent health
- Section 285g–9: Fragile X
- Section 285g–10: Investment in tomorrow’s pediatric researchers
- Subpart 8: national institute of dental research
- Subpart 9: national eye institute
- Subpart 10: national institute of neurological disorders and stroke
- Subpart 11: national institute of general medical sciences
- Subpart 12: national institute of environmental health sciences
- Section 285l: Purpose of Institute
- Section 285l–1: Applied Toxicological Research and Testing Program
- Section 285l–2: Definitions
- Section 285l–3: Interagency Coordinating Committee on the Validation of Alternative Methods
- Section 285l–4: Federal agency action
- Section 285l–5: Application
- Section 285l–6: Methods of controlling certain insect and vermin populations
- Subpart 13: national institute on deafness and other communication disorders
- Section 285m: Purpose of Institute
- Section 285m–1: National Deafness and Other Communication Disorders Program
- Section 285m–2: Data System and Information Clearinghouse
- Section 285m–3: Multipurpose deafness and other communication disorders center
- Section 285m–4: National Institute on Deafness and Other Communication Disorders Advisory Board
- Section 285m–5: Interagency Coordinating Committee
- Section 285m–6: Limitation on administrative expenses
- Subpart 14: national institute on alcohol abuse and alcoholism
- Subpart 15: national institute on drug abuse
- Subpart 16: national institute of mental health
- Subpart 17: national institute of nursing research
- Section 285q: Purpose of Institute
- Section 285q–1: Specific authorities
- Section 285q–2: Advisory council
- Section 285q–3: Repealed. Pub. L. 114–255, div. A, title II, § 2042(h)(1), Dec. 13, 2016, 130 Stat. 1073
- Subpart 18: national institute of biomedical imaging and bioengineering
- Subpart 19: national human genome research institute
- Subpart 20: national institute on minority health and health disparities
- Section 285t: Purpose of Institute
- Section 285t–1: Centers of excellence for research education and training
- Section 285t–2: Repealed. Pub. L. 114–255, div. A, title II, § 2022(c)(1), Dec. 13, 2016, 130 Stat. 1054
- Section 285t–3: General provisions regarding the Institute
Part D: National Library of Medicine
- Subpart 1: general provisions
- Section 286: National Library of Medicine
- Section 286a: Board of Regents
- Section 286a–1: Library facilities
- Section 286a–2: Repealed. Pub. L. 109–482, title I, § 103(b)(39), Jan. 15, 2007, 120 Stat. 3688
- Subpart 2: financial assistance
- Section 286b: Repealed. Pub. L. 103–43, title XIV, § 1402(b), June 10, 1993, 107 Stat. 171
- Section 286b–1: Definitions
- Section 286b–2: National Medical Libraries Assistance Advisory Board
- Section 286b–3: Grants for training in medical library sciences
- Section 286b–4: Assistance for projects in sciences related to health, for research and development in medical library science, and for development of education technologies
- Section 286b–5: Grants for establishing, expanding, and improving basic resources of medical libraries and related instrumentalities
- Section 286b–6: Grants and contracts for establishment of regional medical libraries
- Section 286b–7: Financial support of biomedical scientific publications
- Section 286b–8: Grant payments, records, and audit
- Subpart 3: national center for biotechnology information
- Subpart 4: national information center on health services research and health care technology
Part E: Other Agencies of NIH
- Subpart 1: national center for advancing translational sciences
- Subpart 2: john e. fogarty international center for advanced study in health sciences
- Subpart 3: national center for human genome research
- Subpart 4: office of dietary supplements
- Subpart 5: national center for complementary and integrative health
- Subpart 6: transferred
Part G: Awards and Training
- Section 288: Ruth L. Kirschstein National Research Service Awards
- Section 288–1: Intramural loan repayment program
- Section 288–2: Extramural loan repayment program
- Section 288–3: Repealed. Pub. L. 114–255, div. A, title II, § 2022(c)(2), Dec. 13, 2016, 130 Stat. 1054
- Section 288–4: Undergraduate scholarship program regarding professions needed by National Research Institutes
- Section 288–5 to 288–6: Repealed. Pub. L. 114–255, div. A, title II, § 2022(c)(3)–(5), Dec. 13, 2016, 130 Stat. 1054
- Section 288a: Visiting Scientist Awards
- Section 288b: Studies respecting biomedical and behavioral research personnel
Part H: General Provisions
- Section 289: Institutional review boards; ethics guidance program
- Section 289a: Peer review requirements
- Section 289a–1: Certain provisions regarding review and approval of proposals for research
- Section 289a–2: Inclusion of women and minorities in clinical research
- Section 289b: Office of Research Integrity
- Section 289b–1: Protection against financial conflicts of interest in certain projects of research
- Section 289c: Research on public health emergencies
- Section 289c–1: Collaborative use of certain health services research funds
- Section 289d: Animals in research
- Section 289e: Use of appropriations
- Section 289f: Gifts and donations; memorials
- Section 289g: Fetal research
- Section 289g–1: Research on transplantation of fetal tissue
- Section 289g–2: Prohibitions regarding human fetal tissue
- Section 289g–3: Breast implant research
- Section 289g–4: Support for emergency medicine research
- Section 289g–5: Precision medicine initiative
- Section 289h: Repealed. Pub. L. 103–43, title I, § 121(b)(2), June 10, 1993, 107 Stat. 133
- Section 290: National Institutes of Health Management Fund; establishment; advancements; availability; final adjustments of advances
- Section 290a: Victims of fire